Product name:Mupirocin(BRL-4910A;pseudomonas acid A)
Description: Mupirocin, also known as pseudomonas acid A, is an ideal skin surface antibacterial preparation. It was marketed by GlaxoSmithKline under the trade name of "Bactroban" in 1985 . The US FDA approved the drug to be used in the United States in 1987, and my country approved the production and sale of the drug in 1993 by Sino-American Schick Pharmaceuticals. Mupirocin is mainly used to prevent and treat skin bacterial infections caused by gram-positive cocci, such as impetigo, boils, folliculitis and other primary skin infections, as well as eczema co-infection, ulcer co-infection, and trauma co-infection Infection and other secondary skin infections. The main mechanism of mupirocin's antibacterial effect is to inhibit protein synthesis in bacteria.
Thank You for your valuable time. We have received your details and will get back to you shortly.